$42.11
-0.49-1.15%
Last update: Aug 20, 12:06 PM
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
First Trust Nasdaq Pharmaceuticals ETF (FTXH) Stock Price, Quote, News & History
FTXHNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
1.02B
Fund Score
Loading...
Key Statistics
Open
$42.18
High
$42.24
52 Wk High
$42.87
AUM
1.02B
Dividend
$0.41
Ex-Div Date
Jun 25, 2026
Volume
11K
Market Cap
$184.35B
Mgmt Fee
0.6%
P/E Ratio
23.33
Prev. Close
$42.60
Low
$41.79
52 Wk Low
$27.30
Shares Out
750.00K
Yield
0.96%
Div. Freq
-
Avg. Volume Daily
1.22M
Beta
0.45
Avg. Expense Ratio
0.60%
P/B Ratio
3.81
Recent First Trust Nasdaq Pharmaceuticals ETF News
FAQ
Q
How do I buy First Trust Nasdaq Pharmaceuticals ETF (FTXH) stock?
A
You can purchase shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) through any online brokerage.
Q
Who are First Trust Nasdaq Pharmaceuticals ETF (FTXH) competitors?
A
There are no as such competitors for First Trust Nasdaq Pharmaceuticals ETF.
Q
What is the forecast, or price target, for First Trust Nasdaq Pharmaceuticals ETF (FTXH) stock?
A
There is no analysis for First Trust Nasdaq Pharmaceuticals ETF to provide a consensus price target.
Q
What is the current price for First Trust Nasdaq Pharmaceuticals ETF (FTXH)?
A
The stock price for First Trust Nasdaq Pharmaceuticals ETF (NASDAQ: FTXH) is $42.11 last updated August 20, 2026 at 12:06 PM EDT.
Q
Does First Trust Nasdaq Pharmaceuticals ETF (FTXH) pay a dividend?
A
There are no upcoming dividends for First Trust Nasdaq Pharmaceuticals ETF.
Q
When is First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) reporting earnings?
A
First Trust Nasdaq Pharmaceuticals ETF does not have any upcoming earnings scheduled.
Q
Is First Trust Nasdaq Pharmaceuticals ETF (FTXH) going to split?
A
There is no upcoming split for First Trust Nasdaq Pharmaceuticals ETF.
Key Statistics
Open
$42.18
High
$42.24
52 Wk High
$42.87
AUM
1.02B
Dividend
$0.41
Ex-Div Date
Jun 25, 2026
Volume
11K
Market Cap
$184.35B
Mgmt Fee
0.6%
P/E Ratio
23.33
Prev. Close
$42.60
Low
$41.79
52 Wk Low
$27.30
Shares Out
750.00K
Yield
0.96%
Div. Freq
-
Avg. Volume Daily
1.22M
Beta
0.45
Avg. Expense Ratio
0.60%
P/B Ratio
3.81
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | High Performer-Mid Growth |
| Investment Style | Large Cap Blend |
| Fund Inception | Sep 20, 2016 |
| Managers | David G. McGarel Chris A. Peterson Jon C. Erickson Stan Ueland Roger F. Testin Erik Russo Daniel J. Lindquist |
| Definition | This equity fund portfolio contains majority of stocks with strong financial performance and average growth potential |
Investment Policy
The Fund will normally invest at least 90 percent of its net assets (including investment borrowings) in the securities that comprise the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Index is owned and is developed, maintained and sponsored by Nasdaq, Inc. (the Index Provider). The Index Provider may, from time to time, exercise reasonable discretion as it deems appropriate in order to ensure Index integrity.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved